Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Placebo-controlled
100%
Renal Failure
100%
Synbiotics
100%
Indoxyl Sulfate
100%
Gut Microbiology
100%
Randomized Crossover
100%
Synbiotic Effects
80%
Kidney Disease Progression
60%
Cardiovascular Disease
40%
Chronic Kidney Disease
40%
Uremic Toxins
40%
Unbound Concentration
40%
Probiotics/prebiotics
40%
Placebo
20%
Quality of Life
20%
Cardiovascular Risk
20%
New Zealand
20%
Clinical Trial Registry
20%
Intervention Studies
20%
Inflammation
20%
Estimated Glomerular Filtration Rate
20%
Number of Trials
20%
Potential Treatments
20%
Clinical Benefit
20%
Albuminuria
20%
Lipopolysaccharide
20%
Pre-dialysis
20%
Oxidative Stress Markers
20%
Sulfate Concentration
20%
Stool Microbiome
20%
Gastrointestinal Diseases
20%
Urinary Kidney Injury molecule-1
20%
Proteinuria
20%
Ultra-performance Liquid Chromatography
20%
Chronic Kidney Disease Stage
20%
Quality Intervention
20%
Promising Strategies
20%
Targeted Treatment
20%
Date Quality
20%
Renal Tubule
20%
Kidney Injury
20%
Self-assessed
20%
Toxins Levels
20%
Moderate to Severe
20%
Community Structure
20%
Trimethylamine N-oxide
20%
Probiotic Supplementation
20%
Microbiota
20%
Novel Treatments
20%
Large Intestine
20%
Patient Will
20%
Nutritional Therapy
20%
Immunology and Microbiology
Ultra High Performance Liquid Chromatography
16%
Large Intestine
16%
Pharmacology, Toxicology and Pharmaceutical Science